CIK 0001509745 · Non-accelerated filer<br>Smaller reporting company
CYPHERPUNK TECHNOLOGIES INC.
Sign in to watch- Ticker
- CYPH
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 274412575
- Phone
- 617 252 4343
- Business address
- 47 THORNDIKE STREET, SUITE B1-1, CAMBRIDGE, MA, 02142
- Former names
- LEAP THERAPEUTICS, INC., Dekkun Corp
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $888,900
- in 3 filings
Net −$888,900. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-01-26 | Mirabelli Christopher Director | Grant or award · Restricted Stock Units | +50,000 | 50,000 | ||
| 2021-01-26 | Granfield Christine VP, Head of Reg Affairs/Qual | Grant or award · Employee Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2021-01-26 | O'Mahony John Mark Chief Manufacturing Officer | Grant or award · Employee Stock Option (Right to Buy) | +150,000 | 150,000 | ||
| 2021-01-26 | O'Mahony John Mark Chief Manufacturing Officer | Grant or award · Restricted Stock Units | +50,000 | 50,000 | ||
| 2021-01-26 | Sirard Cynthia Chief Medical Officer | Grant or award · Employee Stock Option (Right to Buy) | +150,000 | 150,000 | ||
| 2021-01-26 | Sirard Cynthia Chief Medical Officer | Grant or award · Restricted Stock Units | +50,000 | 50,000 | ||
| 2021-01-26 | LAWLOR AUGUSTINE Chief Operating Officer | Grant or award · Employee Stock Option (Right to Buy) | +150,000 | 150,000 | ||
| 2021-01-26 | LAWLOR AUGUSTINE Chief Operating Officer | Grant or award · Restricted Stock Units | +50,000 | 50,000 | ||
| 2021-01-26 | ONSI DOUGLAS E CEO,CFO,Pres.,GC,Treas.,&Sec. | Grant or award · Employee Stock Option (Right to Buy) | +175,000 | 175,000 | ||
| 2021-01-26 | ONSI DOUGLAS E CEO,CFO,Pres.,GC,Treas.,&Sec. | Grant or award · Restricted Stock Units | +75,000 | 75,000 | ||
| 2021-01-04 | Mashiach Nissim Director | Grant or award · Stock Option (Right to Buy) | +32,300 | 32,300 | ||
| 2021-01-04 | Dietz Thomas John Director | Grant or award · Stock Option (Right to Buy) | +37,300 | 37,300 | ||
| 2021-01-04 | CAVANAUGH JAMES H Director | Grant or award · Stock Option (Right to Buy) | +32,300 | 32,300 | ||
| 2021-01-04 | LI WILLIAM Director | Grant or award · Stock Option (Right to Buy) | +32,300 | 32,300 | ||
| 2021-01-04 | LOSCALZO JOSEPH Director | Grant or award · Stock Option (Right to Buy) | +32,300 | 32,300 | ||
| 2020-12-28 | HealthCare Ventures VIII, L.P. 10% owner | Other disposition | −2,618,406 | 0 | ||
| 2020-08-10 | ONSI DOUGLAS E CEO, Pres.,GC, Treas., & Sec. | Grant or award · Employee Stock Option (Right to Buy) | +75,000 | 75,000 | ||
| 2020-08-10 | Sirard Cynthia Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +75,000 | 75,000 | ||
| 2020-08-10 | LAWLOR AUGUSTINE Chief Operating Officer | Grant or award · Stock Option (Right to Buy) | +75,000 | 75,000 | ||
| 2020-08-10 | Mashiach Nissim Director | Grant or award · Stock Option (Right to Buy) | +10,000 | 10,000 |
Page 13 of 18 · 348 trades